CL2018001680A1 - Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum - Google Patents

Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum

Info

Publication number
CL2018001680A1
CL2018001680A1 CL2018001680A CL2018001680A CL2018001680A1 CL 2018001680 A1 CL2018001680 A1 CL 2018001680A1 CL 2018001680 A CL2018001680 A CL 2018001680A CL 2018001680 A CL2018001680 A CL 2018001680A CL 2018001680 A1 CL2018001680 A1 CL 2018001680A1
Authority
CL
Chile
Prior art keywords
methods
nrrl
lactobacillus fermentum
compositions
new strains
Prior art date
Application number
CL2018001680A
Other languages
English (en)
Inventor
Galland Belinda Vallejo
Córdova Aarón Fernando González
Quezada José Antonio Feregrino
Quezada Juan Carlos Feregrino
Original Assignee
Dairy A Day Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dairy A Day Inc filed Critical Dairy A Day Inc
Publication of CL2018001680A1 publication Critical patent/CL2018001680A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

ACÁ SE SUMINISTRAN CEPAS NOVEDOSAS DE LACTOBACILLUS FERMENTUM, NRRL B-67059 O NRRL B-67060, COMPOSICIONES QUE CONTIENEN LAS CEPAS NRRL B-67059 O NRRL B-67060, Y PRODUCTOS LÁCTEOS FERMENTADOS Y COMPUESTOS BIOACTIVOS PREPARADOS USANDO LAS CEPAS NRRL B-67059 O NRRL B-67060. TAMBIÉN SE SUMINISTRAN MÉTODOS PARA MODULAR EL SISTEMA INMUNE DE UN SUJETO.
CL2018001680A 2015-12-24 2018-06-20 Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum CL2018001680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562387474P 2015-12-24 2015-12-24

Publications (1)

Publication Number Publication Date
CL2018001680A1 true CL2018001680A1 (es) 2018-11-30

Family

ID=59088233

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2018001680A CL2018001680A1 (es) 2015-12-24 2018-06-20 Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
CL2020001975A CL2020001975A1 (es) 2015-12-24 2020-07-29 Composiciones y metodos de uso de cepas novedosas de lactobacillus fermentum. (divisional solicitud 201801680)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2020001975A CL2020001975A1 (es) 2015-12-24 2020-07-29 Composiciones y metodos de uso de cepas novedosas de lactobacillus fermentum. (divisional solicitud 201801680)

Country Status (13)

Country Link
US (2) US11071760B2 (es)
EP (1) EP3393484A4 (es)
JP (2) JP7121996B2 (es)
CN (1) CN108495643A (es)
BR (1) BR112018013052A2 (es)
CA (1) CA3008175A1 (es)
CL (2) CL2018001680A1 (es)
CO (1) CO2018007607A2 (es)
CR (1) CR20180376A (es)
EA (1) EA201891508A1 (es)
IL (1) IL260181B (es)
MX (1) MX2018007780A (es)
WO (1) WO2017112945A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114774302B (zh) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 植物乳杆菌cqpc02在制备用于预防和/或治疗狼疮性肾炎的产品中的应用
CN114517171B (zh) * 2022-03-17 2023-11-28 江南大学 一株可促进肠道分泌IgA的发酵乳杆菌CCFM1225及其应用
CN114540247B (zh) * 2022-03-17 2023-11-28 江南大学 一株可提高肠道IgA水平并缓解肠炎的发酵乳杆菌CCFM1226及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066343A (en) * 1998-05-13 2000-05-23 Nutribiotech, Llc Methods and compositions for making fermented cereal products
EP1541673B1 (en) * 2000-05-25 2007-04-04 Société des Produits Nestlé S.A. Probiotics for pet food applications
MXPA05010696A (es) 2003-04-02 2006-04-18 Axcan Pharma S A Cepa de lactobacillus fermentum y usos de la misma.
EP1997499A1 (en) 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
TWI383798B (zh) * 2010-04-27 2013-02-01 Syngen Biotech Co Ltd 改善口腔內細菌群的發酵乳酸桿菌ＳＧ－Ａ９５（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｆｅｒｍｅｎｔｕｍ ＳＧ－Ａ９５）及其保健組合物
JP5887062B2 (ja) 2011-03-30 2016-03-16 国立研究開発法人海洋研究開発機構 新規有用深海細菌
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof

Also Published As

Publication number Publication date
CA3008175A1 (en) 2017-06-29
CO2018007607A2 (es) 2018-11-13
IL260181A (en) 2018-07-31
EA201891508A1 (ru) 2019-03-29
JP2022140607A (ja) 2022-09-26
WO2017112945A1 (en) 2017-06-29
EP3393484A4 (en) 2019-06-12
CR20180376A (es) 2018-11-09
CN108495643A (zh) 2018-09-04
BR112018013052A2 (pt) 2018-12-04
IL260181B (en) 2022-03-01
US11071760B2 (en) 2021-07-27
JP7121996B2 (ja) 2022-08-19
CL2020001975A1 (es) 2020-12-04
US20220000950A1 (en) 2022-01-06
MX2018007780A (es) 2019-05-23
US20170182101A1 (en) 2017-06-29
EP3393484A1 (en) 2018-10-31
JP2019506448A (ja) 2019-03-07

Similar Documents

Publication Publication Date Title
CO2019000099A2 (es) Composiciones que comprenden cepas bacterianas
CO2017001994A2 (es) Compuestos activos hacia bromodominios
SG10201803042PA (en) Anti-tim-3 antibodies
MY191581A (en) Anti-pd-1 antibodies
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
PH12017500836A1 (en) Transdermal formulations
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
CL2016002223A1 (es) Microorganismo recombinante que expresa análogos de avermectina y uso de los mismos.
MX2016014564A (es) Vacuna contra la acinetobacter baumannii obtenida a partir de componentes celulares carentes de lipopolisacarido.
GT201700063A (es) Moduladores de pirrolopiridina de rorc2 sustituidos con metilo y trifluorometilo y métodos de uso de los mismos
MY191539A (en) Streptococcal vaccine
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
CL2018000111A1 (es) Microorganismos para la producción de putrescina u ornitina y procedimiento para la producción de putrescina u ornitina usando los mismos
BR112017005524A2 (pt) segmentos de rna viral como agentes imunomoduladores e componentes de vacina
BR112016023752A2 (pt) utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
MY167705A (en) Smokeless Incinerator and System Using the Same
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
ZA201805159B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
GEP20196977B (en) Pharmaceutical formulations of vildagliptin
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina